Over 12 months, Precigen, Inc. saw more selling than buying from its insiders — purchases of about $25,000 against sales of $44.8 million.
The largest purchase came from AGEE NANCY H (Director), about $25,000.
Big money check: 211 institutions held PGEN as of Q2 2026, and more funds bought than sold. Quarter by quarter: 5 quarters in a row of net selling by insiders. Insiders bought in 2 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Aug 28, 2026 | KINDLER JEFFREY B | Director | Sell | 185,000 | $7.44 | $1.4M | SEC |
| Aug 25, 2026 | AGEE NANCY H | Director | Buy | 3,411 | $7.23 | $25K | SEC |
| Aug 25, 2026 | Shah Rutul R | COO | Sell | 34,658 | $7.50 | $260K | SEC |
| Aug 25, 2026 | Shah Rutul R | COO | Sell | 15,342 | $7.50 | $115K | SEC |
| Aug 25, 2026 | Tennant Phil | Executive Officer | Sell | 79,166 | $7.50 | $594K | SEC |
| Aug 7, 2026 | Shah Rutul R | COO | Sell | 32,739 | $6.86 | $225K | SEC |
| Aug 3, 2026 | Shah Rutul R | COO | Sell | 33,772 | $6.50 | $220K | SEC |
| Jul 31, 2026 | Thomasian Harry Jr. | CFO | Sell | 100,000 | $6.06 | $606K | SEC |
| Jul 1, 2026 | Thomasian Harry Jr. | CFO | Sell | 28,571 | $5.78 | $165K | SEC |
| Jul 1, 2026 | Thomasian Harry Jr. | CFO | Sell | 171,429 | $5.53 | $948K | SEC |
| Jul 1, 2026 | Shah Rutul R | COO | Sell | 42,924 | $5.85 | $251K | SEC |
| Jul 1, 2026 | Sabzevari Helen | CEO | Sell | 346,836 | $5.89 | $2.0M | SEC |
| Jun 1, 2026 | Lehr Donald P. | Executive Officer | Sell | 29,131 | $4.36 | $127K | SEC |
| Jun 1, 2026 | Sabzevari Helen | CEO | Sell | 119,250 | $4.36 | $520K | SEC |
| Jun 1, 2026 | Thomasian Harry Jr. | CFO | Sell | 41,884 | $4.36 | $183K | SEC |
In the last 12 months Precigen, Inc. insiders made open-market purchases worth about $25,000 and sales worth about $44.8 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in PGEN was filed on 2026-08-28.
211 investment managers reported holding PGEN in SEC Form 13F filings for Q2 2026.
No congressional trades in PGEN were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).